[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369463-105":59,"doc-detail-369463-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","beyond-fluorodeoxyglucose-molecular-imaging-of-cancer-in-precision-medicine","Beyond fluorodeoxyglucose - Molecular imaging of cancer in precision medicine","","Cancer molecular imaging enables noninvasive visualization of processes altered in neoplasia, including proliferation, glucose metabolism, and receptor expression, supporting patient management. Multiple modalities exist, notably magnetic resonance, optical, and nuclear imaging. Nuclear imaging with 18F-fluorodeoxyglucose PET is widely used for staging and response assessment, but emerging PET tracers and new nuclear probes are increasingly adopted or under investigation. This review highlights probe targets and applications across diverse tumor types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/beyond-fluorodeoxyglucose-molecular-imaging-of-cancer-in-precision-medicine/369463/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/beyond-fluorodeoxyglucose-molecular-imaging-of-cancer-in-precision-medicine/369463.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does cancer molecular imaging measure and why is it useful for patient management?","Question",{"text":112,"@type":113},"It visualizes processes altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression. These biologic readouts support decisions in patient management.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is FDG PET important in cancer care?",{"text":117,"@type":113},"Fluorine-18 fluorodeoxyglucose PET is widely used for cancer staging and response assessment across multiple cancer types.",{"name":119,"@type":110,"acceptedAnswer":120},"What does this review emphasize beyond FDG PET?",{"text":121,"@type":113},"It focuses on new nuclear medicine probes and PET tracers, including their biologic targets and applications for evaluating different neoplasms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369463,1790219571,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10. 3322/caac.70007  \nREVIEW ARTICLE  \nBeyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine  \nMalik E. Juweid MD 1,2  | Soud F. Al-Qasem MD1  | Fadlo R. Khuri MD3  | Andrea Gallamini MD4  | Philipp Lohmann PhD5,6  |  \nHans-Joachim Ziellenbach Dipl Päd7 | Felix M. Mottaghy MD5,8,9   \n1Department of Radiology and Nuclear Medicine, School of Medicine, University of Jordan, Amman, Jordan  \n2The National Center for Diabetes, Endocrinology, and Genetics, University of Jordan, Amman, Jordan  \n3Division of Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon  \n4Research and Innovation Department, Antoine Lacassagne Cancer Center, Nice, France  \n5Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, Aachen, Germany  \n6Medical Imaging Physics (INM-4), Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany  \n7Department of Health and Social Affairs, Hamburg Distance Learning University, Hamburg, Germany  \n8Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands 9Center of Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD),  \nCologne, Germany  \nCorrespondence  \nMalik E. Juweid, Department of Radiology and Nuclear Medicine, University of Jordan Hospital, Queen Rania Street, Al Jubeiha, Amman 11942, Jordan. [Email:](Email: mjuweid@yahoo.com)[ mjuweid@yahoo.com](Email: mjuweid@yahoo.com)  \nAbstract  \nCancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging. Nuclear imaging, particularly using fluorine-18–fluorodeoxyglucose positron emission tomography, is widely used in the staging and response assessment of multiple cancer types. However, at this writing, new nuclear medicine probes, especially positron emission tomography tracers, are increasingly used or are being investigated for cancer evaluation. This review focuses on these probes, their biologic targets, and the applications or potential applications for their use in the assessment of various neoplasms, including both probes available for commercial use—such as somatostatin receptor ligands in neuroendocrine tumors, prostatespecific membrane antigen ligands in prostate cancer, norepinephrine analogs in neural crest tumors like neuroblastoma, and estrogen analogs in breast cancer—and others in clinical development, such as fibroblast-activating protein inhibitors, C-XC chemokine receptor type 4 ligands, and monoclonal antibodies targeting receptor tyrosine kinases, CD4-positive or CD8-positive tumor-infiltrating lymphocytes, tumor-associated macrophages, and cancer stem cell biomarkers. These developments represent a major step toward the integration of molecular imaging as a powerful tool in precision medicine, with an expectedly significant impact on patient management and outcome.  \nKEYWORDS  \ncancer, estrogen receptor, molecular imaging, positron-emission tomography (PET), precision medicine, prostate-specific membrane antigen (PSMA), somatostatin analogs  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 The Author(s). CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nINTRODUCTION  \nMolecular imaging is the in vivo visualization, characterization, and quantification of biologic processes at the cellular and molecular levels, with specific probes assessing physiologic and pathologic pathways. Cancer molecular imaging is the non","cbCaiox90lkJEP6X","https://ap.wps.com/l/cbCaiox90lkJEP6X","pdf",1707547,17,"English","# Introduction\n## Molecular imaging modalities and PET-based approaches\n# Review Focus: Probes Beyond FDG PET\n## Biologic targets and clinical applications\n## Probes in commercial use vs clinical development\n# Clinical Impact on Precision Medicine","[{\"question\":\"What does cancer molecular imaging measure and why is it useful for patient management?\",\"answer\":\"It visualizes processes altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression. These biologic readouts support decisions in patient management.\"},{\"question\":\"Why is FDG PET important in cancer care?\",\"answer\":\"Fluorine-18 fluorodeoxyglucose PET is widely used for cancer staging and response assessment across multiple cancer types.\"},{\"question\":\"What does this review emphasize beyond FDG PET?\",\"answer\":\"It focuses on new nuclear medicine probes and PET tracers, including their biologic targets and applications for evaluating different neoplasms.\"}]","Beyond fluorodeoxyglucose - Molecular imaging of cancer in precision medicine | PDF",1790182810,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75781d8720b138bde2e2ec4151f46323.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36eb53ecfe43cca5c7f1d527862bdd42.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f32295abc528f16ef0ae0a78e824c4a4.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea259acaf8f5e6ab0d79c15f5279eb2d.webp",980,1287]